Using Portfolio Analysis to Maximize Innovation and Optimize R&D Strategic Planning

Time

Wed, Jun 17 9:00AM
W 09

Title

Using Portfolio Analysis to Maximize Innovation and Optimize R&D Strategic Planning

Abstract Summary

ORAL PRESENTATION SCHEDULED: Wednesday, June 17 in Session #2A at 9:56 - 10:01 am in the Exhibit Hall Poster Area (Hall A entrance)

We conducted portfolio analysis of NIH-funded small businesses program to help identify and address R&D barriers to entry. We also demonstrate the data-driven analysis in developing Druggable Genome Initiative, aimed to discover new drug targets and to seed public and private R&D partnerships.

Poster Presenter

Jean Yuan
MD, PhD,
Senior Portfolio Analyst,
National Institutes of Health (NIH)
United States